Human LPIN2 ORF/cDNA clone-Lentivirus plasmid (NM_014646)

Cat. No.: pGMLP001786
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human LPIN2/ Lentiviral expression plasmid for LPIN2 lentivirus packaging, LPIN2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to LPIN2/ products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $1295.67
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP001786
Gene Name LPIN2
Accession Number NM_014646
Gene ID 9663
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 2691 bp
Gene Alias
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGAATTATGTGGGACAGCTGGCTGGGCAGGTGATTGTCACTGTGAAGGAACTCTACAAGGGCATTAACCAGGCCACCCTCTCTGGGTGCATTGATGTCATCGTGGTACAGCAGCAGGATGGCAGCTATCAGTGTTCACCTTTTCACGTTCGGTTTGGAAAGCTGGGAGTCCTGAGATCCAAAGAGAAAGTGATTGATATAGAAATCAACGGCAGTGCAGTGGATCTTCACATGAAGTTGGGTGATAACGGAGAAGCTTTCTTTGTTGAGGAGACTGAAGAAGAATATGAAAAGCTTCCTGCTTACCTTGCCACCTCACCAATTCCTACTGAAGATCAGTTCTTTAAAGATATTGACACCCCTTTGGTGAAATCGGGTGGAGATGAAACACCATCTCAGAGTTCAGACATCTCACACGTCTTGGAAACAGAGACAATTTTTACTCCAAGTTCTGTGAAAAAGAAAAAACGAAGGAGAAAGAAATACAAACAGGACAGTAAGAAGGAAGAGCAGGCCGCATCTGCTGCTGCAGAAGACACATGTGATGTAGGCGTGAGCTCCGATGATGACAAGGGGGCCCAGGCAGCACGAGGATCTTCAAATGCTTCCTTGAAAGAAGAAGAATGTAAAGAGCCTTTGCTCTTCCATTCTGGGGATCATTACCCCTTATCTGATGGAGATTGGTCCCCTTTAGAGACCACCTATCCCCAGACAGCGTGTCCTAAGAGTGATTCAGAGCTGGAGGTGAAACCTGCGGAGAGCCTGCTCAGATCAGAGTCTCACATGGAGTGGACGTGGGGCGGATTCCCAGAGTCCACCAAGGTCAGCAAAAGAGAACGATCTGACCATCATCCTAGGACAGCTACAATTACACCATCAGAAAATACTCATTTTCGGGTAATTCCCAGTGAGGACAACCTCATCAGTGAAGTTGAGAAGGATGCTTCCATGGAAGACACTGTCTGTACCATAGTGAAGCCCAAACCCAGAGCCCTGGGTACACAGATGAGCGACCCAACATCTGTGGCAGAGCTTCTCGAACCTCCTCTTGAGAGTACTCAGATTTCATCTATGTTAGATGCTGACCACCTTCCCAACGCAGCCTTAGCGGAGGCGCCCTCAGAATCCAAACCGGCAGCTAAAGTAGACTCGCCGTCAAAGAAGAAAGGTGTTCACAAAAGAAGCCAACACCAGGGACCTGATGATATTTACCTTGATGACTTAAAGGGTCTAGAACCTGAAGTTGCAGCTCTTTATTTCCCTAAAAGTGAATCGGAGCCCGGTTCCAGGCAGTGGCCCGAGTCTGACACACTCTCTGGCTCCCAGTCCCCACAGTCCGTGGGAAGCGCAGCTGCAGATAGCGGCACCGAGTGCCTCTCAGATTCTGCCATGGACTTGCCTGACGTTACCCTCTCCCTTTGCGGGGGCCTCAGTGAAAATGGAGAAATTTCAAAAGAAAAATTCATGGAGCATATCATTACTTATCACGAATTTGCAGAAAACCCTGGACTTATAGACAATCCTAACCTTGTAATAAGGATATATAATCGTTACTATAACTGGGCTTTGGCAGCTCCCATGATCCTTAGCTTGCAAGTATTCCAGAAGAGCTTGCCTAAGGCCACAGTTGAGTCCTGGGTGAAAGACAAGATGCCAAAGAAATCTGGTCGCTGGTGGTTTTGGCGAAAGAGAGAAAGCATGACCAAACAGCTGCCAGAATCCAAGGAGGGAAAATCTGAGGCACCGCCAGCCAGTGACCTGCCATCCAGCTCCAAGGAGCCGGCCGGTGCCAGGCCGGCCGAGAATGACTCCTCGAGTGACGAGGGATCACAGGAGCTCGAAGAATCCATCACAGTGGACCCCATCCCCACAGAGCCCCTGAGCCACGGCAGCACAACTTCATATAAGAAGTCTCTCCGCCTCTCCTCAGACCAGATCGCAAAACTGAAGCTCCACGATGGCCCAAATGATGTTGTGTTTAGTATTACAACCCAGTATCAAGGCACCTGTCGCTGTGCAGGGACCATTTACCTGTGGAACTGGAATGACAAGATCATCATTTCTGATATTGATGGGACAATAACCAAGTCGGATGCTTTGGGACAGATTCTCCCACAGCTGGGCAAAGACTGGACCCACCAGGGTATAGCAAAGCTCTACCATTCCATCAATGAGAATGGCTACAAGTTTCTGTACTGCTCGGCTCGTGCCATCGGCATGGCCGACATGACCCGTGGCTACCTGCACTGGGTCAATGACAAGGGCACAATCTTGCCCCGGGGCCCCCTGATGCTGTCCCCCAGCAGCTTGTTCTCCGCCTTCCACAGAGAAGTGATAGAAAAGAAACCAGAGAAGTTCAAAATTGAGTGTCTAAATGATATCAAGAATCTGTTTGCCCCGTCTAAGCAGCCCTTCTATGCTGCCTTTGGAAACCGTCCAAATGATGTCTATGCCTACACACAAGTTGGAGTTCCAGACTGTAGAATATTCACCGTGAACCCCAAGGGTGAATTAATACAAGAAAGAACCAAAGGAAACAAGTCATCGTATCACAGGCTGAGTGAGCTCGTGGAGCATGTGTTCCCCCTTCTCAGTAAGGAGCAGAATTCCGCTTTTCCCTGCCCGGAGTTCAGCTCCTTCTGCTACTGGCGAGACCCGATCCCTGAAGTGGACCTGGATGACCTGTCTTGA
ORF Protein Sequence MNYVGQLAGQVIVTVKELYKGINQATLSGCIDVIVVQQQDGSYQCSPFHVRFGKLGVLRSKEKVIDIEINGSAVDLHMKLGDNGEAFFVEETEEEYEKLPAYLATSPIPTEDQFFKDIDTPLVKSGGDETPSQSSDISHVLETETIFTPSSVKKKKRRRKKYKQDSKKEEQAASAAAEDTCDVGVSSDDDKGAQAARGSSNASLKEEECKEPLLFHSGDHYPLSDGDWSPLETTYPQTACPKSDSELEVKPAESLLRSESHMEWTWGGFPESTKVSKRERSDHHPRTATITPSENTHFRVIPSEDNLISEVEKDASMEDTVCTIVKPKPRALGTQMSDPTSVAELLEPPLESTQISSMLDADHLPNAALAEAPSESKPAAKVDSPSKKKGVHKRSQHQGPDDIYLDDLKGLEPEVAALYFPKSESEPGSRQWPESDTLSGSQSPQSVGSAAADSGTECLSDSAMDLPDVTLSLCGGLSENGEISKEKFMEHIITYHEFAENPGLIDNPNLVIRIYNRYYNWALAAPMILSLQVFQKSLPKATVESWVKDKMPKKSGRWWFWRKRESMTKQLPESKEGKSEAPPASDLPSSSKEPAGARPAENDSSSDEGSQELEESITVDPIPTEPLSHGSTTSYKKSLRLSSDQIAKLKLHDGPNDVVFSITTQYQGTCRCAGTIYLWNWNDKIIISDIDGTITKSDALGQILPQLGKDWTHQGIAKLYHSINENGYKFLYCSARAIGMADMTRGYLHWVNDKGTILPRGPLMLSPSSLFSAFHREVIEKKPEKFKIECLNDIKNLFAPSKQPFYAAFGNRPNDVYAYTQVGVPDCRIFTVNPKGELIQERTKGNKSSYHRLSELVEHVFPLLSKEQNSAFPCPEFSSFCYWRDPIPEVDLDDLS

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-IP2579-Ab Anti-LPIN2 monoclonal antibody
    Target Antigen GM-Tg-g-IP2579-Ag LPIN2 protein
    ORF Viral Vector pGMLP001786 Human LPIN2 Lentivirus plasmid
    ORF Viral Vector vGMLP001786 Human LPIN2 Lentivirus particle


    Target information

    Target ID GM-IP2579
    Target Name LPIN2
    Gene ID 9663, 64898, 695641, 316737, 101087178, 607640, 514448, 100051300
    Gene Symbol and Synonyms 2610511G02Rik,LPIN2
    Uniprot Accession Q92539
    Uniprot Entry Name LPIN2_HUMAN
    Protein Sub-location Introcelluar Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000101577
    Target Classification Not Available

    Mouse studies suggest that this gene functions during normal adipose tissue development and may play a role in human triglyceride metabolism. This gene represents a candidate gene for human lipodystrophy, characterized by loss of body fat, fatty liver, hypertriglyceridemia, and insulin resistance. [provided by RefSeq, Jul 2008]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.